Kimberly-Clark (KMB) Stock Forecast & Price Target

Kimberly-Clark is well positioned by its diversified portfolio of category-leading brands such as Huggies, Kleenex, Kotex, Depend, and Cottonelle, with more than half of sales in personal care and roughly a third in consumer tissue providing resilient demand. Its broad geographic footprint across North America, Europe, Asia, and Latin America, plus the professional segment, supports steady cash generation while management’s productivity actions, automation, and AI should help offset roughly $250M of incremental 2026 cost pressure and sustain 5-6% savings. The pending addition of Kenvue’s consumer health portfolio in the second half of calendar year 2026 could expand the business mix and, alongside expected +1-2% organic sales growth and +4-5% EPS growth in 2026-28, offers meaningful longer-term upside if top-line momentum improves.

Kimberly-Clark is facing a weaker near-term fundamental setup as 3Q26 and 4Q26 estimates point to softer organic sales, with -1.3% 3Q26E revenue growth, -13.0% EPS declines, and a modeled -19.5% EPS drop in 4Q26 driven partly by about $4.9B of issued debt. Margin pressure is also building from $30-50M of incremental freight, logistics, tariff, and fire-related costs, while roughly 80% of input costs are hedged, limiting flexibility and leaving additional gross costs unmodeled if oil rises. Although the KVUE acquisition may broaden the portfolio, it also muddies 4Q26 optics and adds financing costs, while investor skepticism around sustainable organic revenue growth remains elevated amid soft North America momentum and uneven China trends.